Untitled

New study looks at how the testes act as a potential sanctuary site for HIV

April 19, 2016

From left to right: Reina Bendayan, Jean-Pierre Routy and Nicolas Chomont 

 

CanCURE Co-Investigator Dr. Reina Bendayan (University of Toronto) has published a study in collaboration with CanCURE Co-Investigators Dr. Jean-Pierre Routy (Research Institute of the McGill University Health Centre) and Dr. Nicolas Chomont (CHUM Research Centre) in the Journal of antimicrobial chemotherapy. Their work suggests that the testes represent a compartment of the human body which can restrict access of certain antiretroviral drugs used to treat HIV-infected individuals. Hence, the researchers contribute to better understanding how antiretroviral concentrations needed for efficient viral suppression are difficult to reach in this potential sanctuary site for HIV. Portions of this project were presented in 2015 at the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, as well as the 7th International Workshop on HIV Persistence during Therapy in Miami. 

 

Read the article in Journal of antimicrobial chemotherapy >>

 

Further reading in Antimicrobial agents and chemotherapy >>

Please reload

Les membres de CanCURE se réunissent virtuellement pour la 6e assemblée générale annuelle

November 24, 2020

CanCURE members reunite virtually for the 6th Annual General Meeting

November 24, 2020

Félicitations aux laboratoires Chomont et Routy pour leur publication dans Nature Communications!

August 17, 2020

1/2
Please reload

©2019 CanCURE

Follow

  • https://twitter.com/cancurehiv
  • White Facebook Icon
  • White YouTube Icon
  • White LinkedIn Icon